Tuberculosis (TB) is a disease caused by bacteria that spreads through the air when an infected person coughs, sneezes, or speaks. According to the CDC, about 7,700 TB cases were reported in the United States in 2022, though this number has been declining over decades. What many people don't realize is that TB screening is different from TB infection—someone can carry the TB bacteria without ever developing active disease, which is why testing is so important for understanding your health status.
Build Your Credit Score to 800 Step by Step →
TB screening involves testing to detect whether you have TB infection or active TB disease. The difference matters: latent TB infection means you have the bacteria but can't spread it to others and may never get sick. Active TB disease means the infection is growing and you can transmit it. Your doctor might recommend screening if you've been in close contact with someone who has TB, work in healthcare, live in a congregate setting like a shelter, or have certain medical conditions that weaken your immune system.
A free informational guide about TB screening walks you through what the tests involve, what results mean, and what your next steps might look like. This kind of information helps you prepare for conversations with healthcare providers and understand why screening might be recommended for you or your family members. The guide explains the science in straightforward terms so you're not left confused by medical jargon.
Practical takeaway: Understanding TB screening basics before you encounter it in a medical setting means you can ask informed questions and understand why a provider recommends testing, rather than feeling caught off guard.
The TB screening information guide breaks down the two primary testing methods used in the United States: the tuberculin skin test (TST), also called the Mantoux test, and blood tests for TB infection. Knowing the difference helps you understand what to expect if a healthcare provider recommends screening.
Free Guide to Lenovo Laptop Keyboard Light Features →
The tuberculin skin test involves injecting a small amount of purified protein derivative (PPD) just under the skin, usually on your forearm. You return 48 to 72 hours later so a healthcare provider can measure how your skin reacted. A raised bump at the injection site indicates TB infection, though size matters—the measurement threshold differs depending on your risk factors. This test has been used since the early 1900s and remains one of the most common screening tools worldwide.
Blood tests for TB infection, sometimes called interferon-gamma release assays (IGRAs), measure how your immune cells respond to TB antigens in a laboratory. Examples include the QuantiFERON test. Blood tests are newer than the skin test and have some advantages: you only need one visit, results don't depend on reading a skin reaction, and they're not affected by prior BCG vaccination (a TB vaccine used in some countries). The CDC notes that either test is considered reliable for screening.
A good information guide explains why your healthcare provider might choose one test over another. Factors include whether you've had BCG vaccination, whether you can reliably return for the TST reading, and whether you have certain skin conditions that might interfere with reading a skin reaction. The guide helps you understand these practical considerations rather than leaving you wondering why your provider chose a specific test.
Practical takeaway: When you know how both tests work and why one might be recommended over another, you can follow your healthcare provider's guidance with more confidence and fewer surprises during the testing process.
One of the most important sections in a TB screening guide explains what results actually mean, because test outcomes can be confusing. A positive TB test result does not mean you have active TB disease—this is the most critical distinction. A positive result means you have TB infection and should follow up with a healthcare provider for additional evaluation and possibly imaging to determine whether the infection is latent (inactive) or active (growing and potentially contagious).
Free Guide to Cleaning and Caring for Microfiber Cloths →
According to CDC data, about 2.3 million Americans have latent TB infection, but only a fraction will ever develop active TB disease. A positive screening test is your signal to get more information, not a diagnosis. This is exactly why an informational guide dedicates attention to this point: many people misunderstand a positive result as a TB diagnosis, when it's actually the first step in determining what your infection status really means.
A negative TB test result generally means you don't have TB infection, though timing matters. If you were recently exposed to TB, the test might be negative because your immune system hasn't yet developed a response. This is called the window period, and it's why some healthcare providers recommend retesting if you had a recent exposure. The guide explains these nuances so you understand why a negative result sometimes leads to a recommendation for follow-up testing rather than feeling like you're done.
An information guide also explains what happens after you have a test result. If your result is positive, your healthcare provider will likely ask about your symptoms, medical history, and TB exposure. They may order a chest X-ray to look for signs of active TB. If your result is negative, you may be done with screening unless you have ongoing exposure risks. The guide helps you prepare for the conversation that follows any result.
Practical takeaway: Understanding what a positive, negative, or inconclusive result means prevents anxiety and helps you ask your healthcare provider the right follow-up questions about what to do next.
TB screening recommendations aren't one-size-fits-all. Public health agencies identify groups with higher risk of TB exposure or progression from latent to active disease, and a good informational guide explains these categories so you can understand whether screening might be relevant for you or someone in your household.
Get Your Free DMV Walk-In Service Information Guide →
The CDC identifies these higher-risk groups: people recently exposed to someone with active TB disease, people living with HIV, people with medical conditions that weaken immunity (such as diabetes or certain cancers), people taking medications that suppress the immune system, and people who use injection drugs. Additionally, TB is more common in certain geographic regions and among people born in countries where TB is widespread. Healthcare workers, people in prisons or jails, and residents of homeless shelters or congregate living facilities are also screened more frequently because exposure risk is higher.
Another category includes people with symptoms of active TB: persistent cough lasting more than three weeks, chest pain, coughing up blood or mucus, fever, chills, and night sweats. Someone with these symptoms wouldn't go through screening—they'd go directly to diagnostic testing. However, an information guide explains this distinction so you understand that screening is for people without symptoms who might have infection, while diagnostic testing is for people showing TB symptoms.
If you don't fit these risk categories, your healthcare provider may still recommend screening based on your individual circumstances. For example, if you're planning to work in a school or hospital, your employer might require TB screening. The guide helps you think through your own situation and decide whether it's worth discussing screening with your doctor, even if you don't fall into a formal risk category.
Practical takeaway: Reviewing risk factors helps you determine whether TB screening makes sense for you, and this knowledge helps you have a more productive conversation with your healthcare provider about whether testing is necessary.
An informational guide about TB screening doesn't stop at explaining the tests themselves—it walks through what comes after. If your screening test is positive, the standard next step is additional evaluation to determine whether you have latent or active TB. This typically includes a chest X-ray and, if your X-ray shows signs of TB, sputum samples sent to a laboratory to confirm TB bacteria.
Learn About Social Security and Veterans Benefits Changes in 2025 →
For latent TB infection, treatment decisions depend on several factors. Healthcare providers assess your age, immune status, and risk of progression to active disease. The CDC reports that certain medications, most commonly isoniazid, can prevent latent TB from becoming active disease. However, not everyone with latent TB needs treatment—your healthcare provider weighs the benefits and risks for your specific situation. An informational guide explains that this is a conversation you'll have with your provider, not a one-size-fits-all decision made by the test result.
For active TB disease, treatment involves taking multiple medications for several months—typically at least six months. TB medications work well, and treatment success rates are high, but completing the full course is critical because stopping early can lead to drug-resistant TB. The guide explains this so you understand why TB treatment requires commitment and follow-up appointments,
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.